Resistance to Antibody-Drug Conjugates Targeting HER2 in Breast Cancer: Molecular Landscape and Future Challenges by Lorenzo Guidi, Gloria Pellizzari, Paolo Tarantino, Carmine Valenza, Giuseppe Curigliano

Get full text

Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung c... by Ilaria Attili, Carmine Valenza, Carmine Valenza, Celeste Santoro, Celeste Santoro, Gabriele Antonarelli, Gabriele Antonarelli, Pamela Trillo Aliaga, Ester Del Signore, Chiara Catania, Gianluca Spitaleri, Antonio Passaro, Filippo de Marinis

Get full text

Tumor Infiltrating Lymphocytes across Breast Cancer Subtypes: Current Issues for Biomarker Assessment by Carmine Valenza, Beatrice Taurelli Salimbeni, Celeste Santoro, Dario Trapani, Gabriele Antonarelli, Giuseppe Curigliano

Get full text

Evolving treatment landscape of immunotherapy in breast cancer: current issues and future perspectives by Carmine Valenza, Graziella Rizzo, Maria Ilenia Passalacqua, Laura Boldrini, Chiara Corti, Dario Trapani, Giuseppe Curigliano

Get full text

Complex Differential Diagnosis between Primary Breast Cancer and Breast Metastasis from EGFR-Mutated Lung Adenocarcinoma: Case Report and Literature Review by Carmine Valenza, Francesca Maria Porta, Alessandra Rappa, Elena Guerini-Rocco, Giuseppe Viale, Massimo Barberis, Filippo de Marinis, Giuseppe Curigliano, Chiara Catania

Get full text

530 Clinicopathologic features and outcome of patients with microsatellite instable (MSI-H) cancer treated in a Phase I unit by Carmen Criscitiello, Giuseppe Curigliano, Stefania Morganti, Gloria Pellizzari, Paolo Tarantino, Carmen Belli, Edoardo Crimini, Matteo Repetto, Angela Esposito, Marzia Locatelli, Ida Minchella, Eleonora Nicolo’, Luca Boscolo Bielo, Grazia Castellano, Pier Paolo Maria Berton Giachetti, Gabriele Antonarelli, Liliana Ascione, Carmine Valenza, Beatrice Taurelli Salimbeni